Rachel Brightwell, MD

Clinical Assistant Professor

20122017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Rachel Brightwell is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Pemetrexed Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinosarcoma Medicine & Life Sciences
Papillary Carcinoma Medicine & Life Sciences
Asbestos Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2017

Use of hematologic biomarkers during chemotherapy predicts survival in ovarian cancer patients

Brightwell, R., Eng, K. & Lele, S., Jan 1 2017, In : European Journal of Gynaecological Oncology. 38, 3, p. 378-381 4 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Biomarkers
Disease-Free Survival
Drug Therapy
Survival

Docetaxel and nab-paclitaxel are safe alternative options for patients with gynecologic malignancies following hypersensitivity reaction to paclitaxel

Brightwell, R., Handel, E., Eng, K., Grzankowski, K., Frederick, P., Odunsi, K. & Lele, S., Jan 1 2016, In : European Journal of Gynaecological Oncology. 37, 6, p. 800-802 3 p.

Research output: Contribution to journalShort survey

docetaxel
Paclitaxel
Hypersensitivity
Neoplasms
Survival
7 Citations (Scopus)

The CD47 “don't eat me signal” is highly expressed in human ovarian cancer

Brightwell, R., Grzankowski, K. S., Lele, S., Eng, K., Arshad, M., Chen, H. & Odunsi, K., Nov 1 2016, In : Gynecologic Oncology. 143, 2, p. 393-397 5 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Tumor Escape
Immune Evasion
Tumor Microenvironment
Therapeutics

Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator

Grzankowski, K. S., Brightwell, R., Kasznica, J. M. & Odusi, K. O., Jan 1 2015, In : Gynecologic Oncology Reports. 11, p. 10-12 3 p.

Research output: Contribution to journalArticle

Pemetrexed
Asbestos
Ovarian Neoplasms
Malignant Mesothelioma
4 Citations (Scopus)

Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients with Epithelial Ovarian Cancer: A Cohort Study

Kolomeyevskaya, N. V., Szender, J. B., Zirpoli, G., Minlikeeva, A., Friel, G., Cannioto, R. A., Brightwell, R., Grzankowski, K. S. & Moysich, K. B., Nov 1 2015, In : International Journal of Gynecological Cancer. 25, 9, p. 1587-1592 6 p.

Research output: Contribution to journalReview article

Oral Contraceptives
Cohort Studies
Confidence Intervals
Survival
Neoplasms